1. Home
  2. HODO vs CNSP Comparison

HODO vs CNSP Comparison

Compare HODO & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HODO

House of Doge Inc. Common Stock

N/A

Current Price

$0.87

Market Cap

8.4M

ML Signal

N/A

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$5.10

Market Cap

7.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HODO
CNSP
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.3M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
HODO
CNSP
Price
$0.87
$5.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
1.1M
7.7K
Earning Date
N/A
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.03
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.90
52 Week High
$2.52
$10.59

Technical Indicators

Market Signals
Indicator
HODO
CNSP
Relative Strength Index (RSI) 20.09 51.29
Support Level $0.85 $4.54
Resistance Level $1.39 $5.53
Average True Range (ATR) 0.30 0.34
MACD -0.02 -0.00
Stochastic Oscillator 29.29 35.25

Price Performance

Historical Comparison
HODO
CNSP

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: